There, she will develop and implement program aims, participate in strategic decision-making in the Cancer Center, direct pilot project funding, facilitate interactions among Cancer Center members, and assist in the recruiting activities for the 42-member program with over $11.7 million in annual peer-reviewed funding.

Jennifer Pietenpol, PhD, will be recognized at the annual meeting of the American Society of Clinical Oncology (ASCO) with one of its highest honors.

Vanderbilt's James E. Crowe, Jr, MD, and Neil Osheroff, PhD, are among 12 individuals honored by the Association of American Medical Colleges during its 2023 Awards Recognition Event.

Vanderbilt research shows that commensal gut microbes impact the host-pathogen competition for iron and has implications for therapeutic strategies aimed at preventing pathogens from acquiring essential nutrients.

Richard Caprioli, C. David Weaver, Susan Eagle, and Franz Baudenbacher as Master Innovators at Vanderbilt.

The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has funded an ambitious initiative to overcome one of the most perplexing and frustrating mysteries of cancer treatment — how to prevent drug resistance.